Protective effects of erythropoietin on tau phosphorylation induced by β‐amyloid
- 30 May 2008
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 86 (13) , 3018-3027
Abstract
Neuropathological studies have demonstrated that the presence of neurofibrillary tangles (NFTs) is one of the most prominent pathologic characteristics of Alzheimer's disease (AD). The microtubule‐associated protein tau is the major component of NFTs, and its abnormal hyperphosphorylation leads to the destabilization of microtubules, impaired axonal transport, and eventual death of the neurons. The hematopoietic cytokine erythropoietin (Epo) is now considered as a viable agent with regard to central nervous system injury in a variety of cellular systems. Here we report that Epo prevented tau hyperphosphorylation in SH‐SY5Y cells exposed to the β‐amyloid peptide and that this effect may depend on the PI3K/Akt‐GSK‐3β pathway. This study provides new molecular insight into the neuroprotective effect of Epo and suggests its possible therapeutic role in the management of AD.Keywords
This publication has 80 references indexed in Scilit:
- Erythropoietin promotes survival of primary human endothelial cells through PI3K-dependent, NF-κB-independent upregulation of Bcl-xLAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Mitogen activated protein kinase and protein kinase C activation mediate promotion of sAPPα secretion by deprenylNeurochemistry International, 2007
- Comparative study of endoplasmic reticulum stress-induced neuronal death in rat cultured hippocampal and cerebellar granule neuronsNeurochemistry International, 2006
- Aβ(31–35) peptide induce apoptosis in PC 12 cells: Contrast with Aβ(25–35) peptide and examination of underlying mechanismsNeurochemistry International, 2005
- The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer’s disease-like tau phosphorylationBiochemical and Biophysical Research Communications, 2004
- Involvement of glycogen synthase kinase‐3β and tau phosphorylation in neuronal Golgi disassemblyJournal of Neurochemistry, 2002
- Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 DegradationJournal of Biological Chemistry, 2002
- Mitogen-activated Protein Kinase Plays an Essential Role in the Erythropoietin-dependent Proliferation of CTLL-2 CellsJournal of Biological Chemistry, 2000
- Alzheimer's Disease. Basic Aspects.Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 2000
- Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinaseNeuroscience Letters, 1992